China's Sinovac will submit an application in several countries for clinical research and emergency use on vaccines targeting the Gamma and Delta variants, Sinovac CEO, Yin Weidong, said on Thursday during
ines hosted by Chinese State Councilor and Foreign Minister Wang Yi.
The Global Times learned that the vaccines mentioned by Yin would be new products,
different from the CoronaVac shot currently available in the market, and are
especially designed for specific variants.
The new products, if successfully developed and approved in other countries, would be supplied depending on the dominating local variant, the Global Times learned.
Yin noted during Thursday's forum that Sinovac is able to produce
different kinds of vaccines targeting different variants, according to a document shared by the company with the Global Times.
Yin said that Sinovac has also finished research on booster shots of CoronaVac, which shows that booster shots can quickly increase the level of neutralizing antibodies within one week. The results would soon be published on Science